US OptionsDetailed Quotes
ESPR241220C4500
- 0.13
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
0.13Open0.13Pre Close0 Volume292 Open Interest4.50Strike Price0.00Turnover456.73%IV105.78%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.2131Delta0.2068Gamma17.31Leverage Ratio-0.0297Theta0.0001Rho3.69Eff Leverage0.0009Vega
Esperion Therapeutics Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$
gone for good ? 😢
gone for good ? 😢
2
$Esperion Therapeutics (ESPR.US)$
Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel
Esperion Therapeutics (NASDAQ: ESPR) has entered into a licensing agreement with Neopharm Israel for exclusive commercialization rights of NEXLETOL® and NEXLIZET® in Israel. The agreement includes an upfront payment, near-term milestone payments, and tiered royalties on product sales.
Under the agreement terms, Neopharm will rece...
Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel
Esperion Therapeutics (NASDAQ: ESPR) has entered into a licensing agreement with Neopharm Israel for exclusive commercialization rights of NEXLETOL® and NEXLIZET® in Israel. The agreement includes an upfront payment, near-term milestone payments, and tiered royalties on product sales.
Under the agreement terms, Neopharm will rece...
2
$Esperion Therapeutics (ESPR.US)$ Reuters
1 min ago
Esperion Partners With Neopharm to Commercialize Nexletol® (Bempedoic Acid) and Nexlizet® (Bempedoic Acid and Ezetimibe) in Israel! Esperion Therapeutics Inc: Under Terms of Agreement, Esperion Will Receive an Upfront and Near-Term Milestone Payments
1 min ago
Esperion Partners With Neopharm to Commercialize Nexletol® (Bempedoic Acid) and Nexlizet® (Bempedoic Acid and Ezetimibe) in Israel! Esperion Therapeutics Inc: Under Terms of Agreement, Esperion Will Receive an Upfront and Near-Term Milestone Payments
1
2
$Esperion Therapeutics (ESPR.US)$ Best buy in is when it reach USD2
$Esperion Therapeutics (ESPR.US)$ wjy is thus happening
4
$Esperion Therapeutics (ESPR.US)$ will this come back tomorrow?
3
$Esperion Therapeutics (ESPR.US)$ big sell off today? 🤔
7
$Esperion Therapeutics (ESPR.US)$ breaking $ 4 🥰
6
3
No comment yet
Youngman : Hang in there guys
Drassasin : I hope this stock can make us all wealthy.
74480569 : Why do we have to pay 5.75% interest when the interest rate has been lowered?
AB84 OP 74480569 : Risk
74480569 : This dish is too scary.
View more comments...